Get a Free Listing!
All Categories

CMC Analytical Comparability Training

Date: 10-Sep-12 to 11-Sep-12
Location: Hilton Stadtpark / Vienna / Austria
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

Biologics, Biosimilars and Biobetters are considered the growth engine of the pharmaceutical industry. Currently the global market for biologics presents more than $ 130 billion. By 2016, the eight out of the ten blockbuster drugs will go off patent opening up the doors for generics and biosimilars. Becoming a steadily growing new field of biopharmaceutical development and bringing along safety and efficiency challenges, Fleming Europe has organized the CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars & Biobetters.

Visitors

Vice Presidents, Directors, Heads, Managers and Scientists involved in:
Biologics, Biosimilars, Biobetters, Copy Biologics, Biopharmaceuticals, Biotechnology, Biotherapeutics, Analytical Science, Process Science, Research & Development, Regulatory Compliance, New Product Development, Quality Assurance, Quality Control, Intellectual Property, Clinical Immunology, Scientific Affairs, Business Development, Portfolio Planning, Commercial Affairs, Legal Affairs, Pharmacovigilance, Branded and Generic Drug, Pharmaceuticals & Biotechnology Companies, CROs/CMOs, Drug Regulators, Academic & Government Bodie

Exhibitors

Carsten Brockmeyer
Managing Director
Brockmeyer Biopharma
Germany

Johannes Buchner
Chair at the department of chemistry
Technische Universitet Munchen
Germany

Martin Bluggel
COO, Executive Vice President
Protagen AG
Germany

Markus Fido
CEO
Vela Pharmaceuticals
Austria

Go to event website